These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28986550)

  • 1. Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
    Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
    Sci Rep; 2017 Oct; 7(1):12754. PubMed ID: 28986550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
    Pautier P; Vergote I; Joly F; Melichar B; Kutarska E; Hall G; Lisyanskaya A; Reed N; Oaknin A; Ostapenko V; Zvirbule Z; Chetaille E; Geniaux A; Shoaib M; Green JA
    Int J Gynecol Cancer; 2017 Feb; 27(2):258-266. PubMed ID: 27870712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models.
    Gozgit JM; Squillace RM; Wongchenko MJ; Miller D; Wardwell S; Mohemmad Q; Narasimhan NI; Wang F; Clackson T; Rivera VM
    Cancer Chemother Pharmacol; 2013 May; 71(5):1315-23. PubMed ID: 23468082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
    Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenretinide: a novel treatment for endometrial cancer.
    Mittal N; Malpani S; Dyson M; Ono M; Coon JS; Kim JJ; Schink JC; Bulun SE; Pavone ME
    PLoS One; 2014; 9(10):e110410. PubMed ID: 25340777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis.
    Wang H; Shi H
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2307-2316. PubMed ID: 34233525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
    Lim MC; Lee S; Seo SS
    Onkologie; 2010; 33(5):260-2. PubMed ID: 20502061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
    Fleming GF; Filiaci VL; Marzullo B; Zaino RJ; Davidson SA; Pearl M; Makker V; Burke JJ; Zweizig SL; Van Le L; Hanjani P; Downey G; Walker JL; Reyes HD; Leslie KK
    Gynecol Oncol; 2014 Mar; 132(3):585-92. PubMed ID: 24456823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Cornelison TL; Baker TR; Piver MS; Driscoll DL
    Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-specific potentiation of glioblastoma drugs by pterostilbene.
    Schmidt L; Baskaran S; Johansson P; Padhan N; Matuszewski D; Green LC; Elfineh L; Wee S; Häggblad M; Martens U; Westermark B; Forsberg-Nilsson K; Uhrbom L; Claesson-Welsh L; Andäng M; Sintorn IM; Lundgren B; Lönnstedt I; Krona C; Nelander S
    Oncotarget; 2016 Nov; 7(45):73200-73215. PubMed ID: 27689322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
    Ma AY; Xie SW; Zhou JY; Zhu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Fiorica JV; Brunetto VL; Hanjani P; Lentz SS; Mannel R; Andersen W;
    Gynecol Oncol; 2004 Jan; 92(1):10-4. PubMed ID: 14751131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate as a biomodulator.
    Chang AY
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):58-61. PubMed ID: 9625385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with paclitaxel, carboplatin and megestrol acetate for the management of advanced stage or recurrent carcinoma of the endometrium: a phase II study.
    Bevis KS; Kilgore LC; Alvarez RD; Straughn JM; Leath CA
    J Reprod Med; 2014; 59(3-4):113-20. PubMed ID: 24724218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.
    Chen G; Xu Z; Chang G; Hou J; Hu L; Zhang Y; Yu D; Li B; Chang S; Xie Y; Zhang Y; Wei R; Wu H; Xiao W; Sun X; Tao Y; Gao L; Dai B; Shi J; Zhu W
    Oncol Rep; 2017 Jul; 38(1):488-496. PubMed ID: 28560392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
    Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate induced proliferation and differentiation of osteoblastic MC3T3-E1 cells: A drug repurposing approach.
    Badran SA; Atia-Tul-Wahab ; Fayyaz S; Taj B; Choudhary MI
    Steroids; 2020 May; 157():108607. PubMed ID: 32084501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
    Cardone A; Tolino A; Di Serio C; Borruto Caracciolo G; Caccavale C
    Eur J Gynaecol Oncol; 1995; 16(6):500-5. PubMed ID: 8536766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.